Protara Therapeutics earnings were -$57.4M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest TARA earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$17.3M, up 30.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TARA reported annual earnings of -$57.4M, with 28.8% growth.
Protara Therapeutics Earnings Reports & History FAQ
What were Protara Therapeutics's earnings last quarter?
Protara Therapeutics (NASDAQ: TARA) reported Q4 2025 earnings per share (EPS) of -$0.38, up 11.63% year over year. Total TARA earnings for the quarter were -$17.31 million. In the same quarter last year, Protara Therapeutics's earnings per share (EPS) was -$0.43.
Is Protara Therapeutics profitable or losing money?
As of the last Protara Therapeutics earnings report, Protara Therapeutics is currently losing money. Protara Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$57.44 million, a 28.8% increase year over year.
What was TARA's earnings growth in the past year?
As of Protara Therapeutics's earnings date in Q1 2026, Protara Therapeutics's earnings has grown year over year. TARA earnings in the past year totalled -$57.44 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.